A case series of BRAF V600E inhibitor (PLX4032) related cutaneous eruptions in metastatic melanoma

被引：0
|
作者：
Sinha, R. [1 ]
Fearfield, L. [2 ]
Larkin, J. [1 ]
机构：
[1] Chelsea & Westminster Hosp NHS Fdn Trust, London, England
[2] Royal Marsden NHS Fdn Trust, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2011年 / 165卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [21] PLX4032, a selective B-RafV600E inhibitor demonstrates potent antitumor activity in preclinical melanoma models
    Su, Fei
    Yang, Hong
    Higgins, Brian
    Kolinsky, Kenneth
    Lee, Richard
    Packman, Kathryn
    Schostack, Kathleen
    Heimbrook, David
    Bollag, Gideon
    CANCER RESEARCH, 2009, 69
  • [22] BRAF V600E mutation as a prognostic factor in cutaneous melanoma patients
    Tas, Faruk
    Erturk, Kayhan
    DERMATOLOGIC THERAPY, 2020, 33 (02)
  • [23] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Del Bufalo, Francesca
    Ceglie, Giulia
    Cacchione, Antonella
    Alessi, Iside
    Colafati, Giovanna Stefania
    Carai, Andrea
    Diomedi-Camassei, Francesca
    De Billy, Emmanuel
    Agolini, Emanuele
    Mastronuzzi, Angela
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [24] Interaction between BRAF inhibitor PLX-4720 and CDK inhibitors can sensitize melanoma cells with BRAF V600E mutation
    Tortelli Junior, Tharcisio Citrangulo
    Chammas, Roger
    Chellappan, Srikumar
    CANCER RESEARCH, 2012, 72
  • [25] Rescue surgery in a patient with metastatic melanoma and BRAF V600E mutation
    de Miguel, Maite
    Jimeno, Jaime
    Vidal, Joana
    Segura, Sonia
    Lorente, Leyre
    CIRUGIA ESPANOLA, 2018, 96 (10): : 665 - 666
  • [26] A new mouse model of BRaf(V600E)-induced metastatic melanoma
    McMahon, Martin
    Dankort, David
    Filenova, Elena
    Curley, David
    Bosenberg, Marcus
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 249 - 249
  • [27] Differential sensitivity of melanoma cell lines with BRAFV600Emutation to the specific Raf inhibitor PLX4032
    Jonas N Søndergaard
    Ramin Nazarian
    Qi Wang
    Deliang Guo
    Teli Hsueh
    Stephen Mok
    Hooman Sazegar
    Laura E MacConaill
    Jordi G Barretina
    Sarah M Kehoe
    Narsis Attar
    Erika von Euw
    Jonathan E Zuckerman
    Bartosz Chmielowski
    Begoña Comin-Anduix
    Richard C Koya
    Paul S Mischel
    Roger S Lo
    Antoni Ribas
    Journal of Translational Medicine, 8
  • [28] Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients
    Tas, F.
    Erturk, K.
    NEOPLASMA, 2019, 66 (04) : 631 - 636
  • [29] BRaf INHIBITOR PLX4720 IS A RADIOSENSITIZER IN HUMAN MALIGNANT ASTROCYTOMAS EXPRESSING THE BRaf V600E MUTATION
    Dasgupta, Tina
    Yang, Xiaodong
    Hashizume, Rintaro
    Gragg, Ashley
    Prados, Michael
    Nicolaides, Theodore
    James, C. David
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2011, 13 : 119 - 119
  • [30] Vemurafenib in Melanoma with BRAF V600E Mutation
    Morita, Hiroyuki
    Nagai, Ryozo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1448
12345